Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

JAVIER AMU,M.D. PROFESSIONAL CORPORATION

NPI: 1346491651 · REEDLEY, CALIFORNIA 93654 · Specialist · NPI assigned 10/06/2008

$10.01M
Total Medicaid Paid
331,428
Total Claims
270,428
Beneficiaries
57
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialAMU, JAVIER (MEDICAL DIRECTOR)
NPI Enumeration Date10/06/2008

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 37,394 $1.49M
2019 59,613 $1.63M
2020 51,332 $1.16M
2021 49,456 $1.60M
2022 47,490 $1.22M
2023 51,147 $1.60M
2024 34,996 $1.31M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
T1015 Clinic visit/encounter, all-inclusive 108,310 85,492 $9.27M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 93,952 68,498 $394K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 9,208 8,672 $44K
0002A 589 341 $33K
0071A 555 325 $31K
0072A 487 313 $28K
0001A 505 281 $27K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 5,166 4,658 $25K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 4,552 4,087 $25K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3,925 3,449 $15K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1,897 1,672 $15K
92551 11,147 10,326 $13K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2,187 1,888 $13K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 6,031 5,467 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 2,527 2,301 $8K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 5,320 5,052 $7K
85018 21,771 19,564 $7K
0003A 120 79 $7K
90686 7,016 6,269 $7K
81000 13,442 12,106 $4K
99173 10,733 10,043 $4K
90670 2,847 2,533 $2K
0081A 29 29 $2K
90651 972 878 $2K
99188 923 893 $2K
90648 2,240 1,923 $2K
17110 183 95 $2K
90734 515 452 $1K
90677 235 207 $1K
90680 1,817 1,587 $1K
90716 1,202 1,049 $1K
90707 1,184 1,026 $1K
90723 1,553 1,289 $1K
90633 1,260 1,096 $1K
0082A 16 16 $1K
96127 1,636 1,590 $1K
86580 890 872 $760.63
90688 297 289 $662.70
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 289 184 $404.60
99000 1,445 1,403 $390.66
90697 559 530 $324.00
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 86 73 $271.88
99381 180 139 $265.61
90661 122 122 $238.96
90700 237 184 $190.80
90674 83 82 $179.40
99461 19 16 $162.00
83655 166 162 $158.60
90715 139 118 $130.50
90696 171 133 $130.50
96150 184 165 $99.46
36400 29 29 $96.50
94760 244 161 $85.10
90620 53 47 $81.90
G8510 Screening for depression is documented as negative, a follow-up plan is not required 62 56 $52.33
99383 17 13 $49.35
36416 104 104 $0.00